BioScrip announces shareholder approval of merger
DENVER: BioScrip, Inc. (NASDAQ: BIOS), the largest independent national provider of infusion and home care management solutions, today announced that its stockholders approved the proposals that are conditions to the proposed merger with Option Care at the Company’s special meeting of stockholders held earlier today.
BioScrip’s merger with Option Care is expected to close on or about August 6, 2019.
BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services.






